Novo Nordisk CEO Lars Fruergaard Jørgensen at a Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Sept. 24, 2024 (Graeme Sloan/Sipa USA/Sipa via AP Images)

September 24, 2024 03:10 PM EDT

FDA+

Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices

Nicole DeFeudis

Editor

Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have agreed not to penalize the company for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

view job offer post your job now

TRENDING NOW

Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

No­vo Nordisk CEO skep­ti­cal of PBM promis­es in Sen­ate hear­ing on weight loss drug prices

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices